A Novel Suspension Formulation Enhances Intestinal Absorption of Macromolecules Via Transient and Reversible Transport Mechanisms

di Tuvia, Shmuel, Pelled, Dori, Marom, Karen, Salama, Paul, Levin-Arama, Maya, Karmeli, Irina, Idelson, Gregory H., Landau, Isaac, Mamluk, Roni
Pubblicazione 2014

Regulation of Soluble Neuropilin 1, an Endogenous Angiogenesis Inhibitor, in Liver Development and Regeneration

di Panigrahy, Dipak, Adini, Irit, Mamluk, Roni, Levonyak, Nicholas, Bruns, Christiane J., D’Amore, Patricia A., Klagsbrun, Michael, Bielenberg, Diane R.
Pubblicato in Pathology (2014)

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer

di Miller Andrew F, Beck Adam W, Sullivan Laura A, Dineen Sean P, Carbon Juliet G, Mamluk Roni, Wong Henry, Brekken Rolf A
Pubblicazione 2008-11-01

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer

di Dineen, Sean P, Sullivan, Laura A, Beck, Adam W, Miller, Andrew F, Carbon, Juliet G, Mamluk, Roni, Wong, Henry, Brekken, Rolf A
Pubblicazione 2008

Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2

di Mamluk, Roni, Carvajal, Irvith M, Morse, Brent A, Wong, Henry, Abramowitz, Janette, Aslanian, Sharon, Lim, Ai-Ching, Gokemeijer, Jochem, Storek, Michael J, Lee, Joonsoo, Gosselin, Michael, Wright, Martin C, Camphausen, Ray T, Wang, Jack, Chen, Yan, Miller, Kathy, Sanders, Kerry, Short, Sarah, Sperinde, Jeff, prasad, Gargi, Williams, Stephen, Kerbel, Robert, ebos, John, Mutsaers, Anthony, Mendlein, John D, Harris, Alan S, Furfine, Eric S
Pubblicazione 2010